Publications - Terry M . Therneau, Ph.D.

Back to Research Profile

1. Kim WR, Terrault NA, Pedersen RA, Therneau TM, Edwards E, Hindman AA, Brosgart CL. Trends in waiting list registration for liver transplantation for viral hepatitis in the United States. Gastroenterology 2009 Nov; 137(5):1680-6. Epub 2009 Jul 24.
   View PubMed
2. Liang KP, Kremers HM, Crowson CS, Snyder MR, Therneau TM, Roger VL, Gabriel SE. Autoantibodies and the risk of cardiovascular events. J Rheumatol 2009 Nov; 36(11):2462-9. Epub 2009 Oct 15.
   View PubMed
3. Dunlay SM, Redfield MM, Weston SA, Therneau TM, Hall Long K, Shah ND, Roger VL. Hospitalizations after heart failure diagnosis a community perspective. J Am Coll Cardiol 2009 Oct 27; 54(18):1695-702.
   View PubMed
4. Myasoedova E, Crowson CS, Maradit-Kremers H, Fitz-Gibbon PD, Therneau TM, Gabriel SE. Total cholesterol and LDL levels decrease before rheumatoid arthritis. Ann Rheum Dis 2009 Oct 23. [Epub ahead of print]
   View PubMed
5. Bida JP, Kyle RA, Therneau TM, Melton LJ 3rd, Plevak MF, Larson DR, Dispenzieri A, Katzmann JA, Rajkumar SV. Disease associations with monoclonal gammopathy of undetermined significance: a population-based study of 17,398 patients. Mayo Clin Proc 2009 Aug; 84(8):685-93.
   View PubMed
6. Tang H, Therneau TM. Statistical Metrics for Quality Assessment of High-Density Tiling Array Data. Biometrics 2009 Jul 23. [Epub ahead of print]
   View PubMed
7. Vachon CM, Kyle RA, Therneau TM, Foreman BJ, Larson DR, Colby CL, Phelps TK, Dispenzieri A, Kumar SK, Katzmann JA, Rajkumar SV. Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significance. Blood 2009 Jul 23; 114(4):785-90. Epub 2009 Jan 29.
   View PubMed
8. Eckel-Passow JE, Oberg AL, Therneau TM, Bergen HR 3rd. An insight into high-resolution mass-spectrometry data. Biostatistics 2009 Jul; 10(3):481-500. Epub 2009 Mar 26.
   View PubMed
9. Davis JM 3rd, Roger VL, Crowson CS, Kremers HM, Therneau TM, Gabriel SE. Reply. Arthritis Rheum 2009 Jul; 60(7):2206-7.
   View PubMed
10. Yun BC, Kim WR, Benson JT, Biggins SW, Therneau TM, Kremers WK, Rosen CB, Klintmalm GB. Impact of pretransplant hyponatremia on outcome following liver transplantation. Hepatology 2009 May; 49(5):1610-5.
    View PubMed
11. Melton LJ 3rd, Kearns AE, Atkinson EJ, Bolander ME, Achenbach SJ, Huddleston JM, Therneau TM, Leibson CL. Secular trends in hip fracture incidence and recurrence. Osteoporos Int 2009 May; 20(5):687-94. Epub 2008 Sep 17.
    View PubMed
12. Therneau T. The perils and promise of high-dimensional biology. Hepatology 2009 Apr; 49(4):1061-2.
    View PubMed
13. Kyle RA, Benson J, Larson D, Therneau T, Dispenzieri A, Melton Iii LJ, Rajkumar SV. IgM monoclonal gammopathy of undetermined significance and smoldering Waldenstrom's macroglobulinemia. Clin Lymphoma Myeloma 2009 Mar; 9(1):17-8.
    View PubMed
14. Icen M, Nicola PJ, Maradit-Kremers H, Crowson CS, Therneau TM, Matteson EL, Gabriel SE. Systemic lupus erythematosus features in rheumatoid arthritis and their effect on overall mortality. J Rheumatol 2009 Jan; 36(1):50-7.
    View PubMed
15. Wettstein P, Strausbauch M, Therneau T, Borson N. The application of real-time PCR to the analysis of T cell repertoires. Nucleic Acids Res 2008 Dec; 36(21):e140. Epub 2008 Oct 03.
    View PubMed
16. Adabag AS, Therneau TM, Gersh BJ, Weston SA, Roger VL. Sudden death after myocardial infarction. JAMA 2008 Nov 5; 300(17):2022-9.
    View PubMed
17. Adabag AS, Therneau TM, Gersh BJ, Weston SA, Roger VL. Sudden death after myocardial infarction. JAMA 2008 Nov 5; 300(17):2022-9.
    View PubMed
18. Snozek CL, Katzmann JA, Kyle RA, Dispenzieri A, Larson DR, Therneau TM, Melton LJ 3rd, Kumar S, Greipp PR, Clark RJ, Rajkumar SV. Prognostic value of the serum free light chain ratio in newly diagnosed myeloma: proposed incorporation into the international staging system. Leukemia 2008 Oct; 22(10):1933-7. Epub 2008 Jul 03.
    View PubMed
19. Kim WR, Biggins SW, Kremers WK, Wiesner RH, Kamath PS, Benson JT, Edwards E, Therneau TM. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med 2008 Sep 4; 359(10):1018-26.
    View PubMed
20. Davis JM 3rd, Roger VL, Crowson CS, Maradit Kremers H, Therneau TM, Gabriel SE. The presentation and outcome of heart failure in patients with rheumatoid arthritis differs from that in the general population. Arthritis Rheum 2008 Sep; 58(9):2603-11.
    View PubMed
21. Davis JM 3rd, Roger VL, Crowson CS, Kremers HM, Therneau TM, Gabriel SE. The presentation and outcome of heart failure in patients with rheumatoid arthritis differs from that in the general population. Arthritis Rheum 2008 Sep; 58(9):2603-11.
    View PubMed
22. Davis JM, Roger VL, Crowson CS, Maradit Kremers H, Therneau TM, Gabriel SE. The presentation and outcome of heart failure in patients with rheumatoid arthritis differs from that in the general population. Arthritis Rheum 2008 Sep; 58(9):2603-11.
    View PubMed
23. Cheville JC, Karnes RJ, Therneau TM, Kosari F, Munz JM, Tillmans L, Basal E, Rangel LJ, Bergstralh E, Kovtun IV, Savci-Heijink CD, Klee EW, Vasmatzis G. Gene panel model predictive of outcome in men at high-risk of systemic progression and death from prostate cancer after radical retropubic prostatectomy. J Clin Oncol 2008 Aug 20; 26(24):3930-6.
    View PubMed
24. Melton LJ 3rd, Leibson CL, Achenbach SJ, Therneau TM, Khosla S. Fracture risk in type 2 diabetes: update of a population-based study. J Bone Miner Res 2008 Aug; 23(8):1334-42.
    View PubMed
25. Hill EG, Schwacke JH, Comte-Walters S, Slate EH, Oberg AL, Eckel-Passow JE, Therneau TM, Schey KL. A statistical model for iTRAQ data analysis. J Proteome Res 2008 Aug; 7(8):3091-101. Epub 2008 Jun 26.
    View PubMed
26. Hill EG, Schwacke JH, Comte-Walters S, Slate EH, Oberg AL, Eckel-Passow JE, Therneau TM, Schey KL. A statistical model for iTRAQ data analysis. J Proteome Res 2008 Aug; 7(8):3091-101.
    View PubMed
27. Kremers HM, Crowson CS, Therneau TM, Roger VL, Gabriel SE. High ten-year risk of cardiovascular disease in newly diagnosed rheumatoid arthritis patients: a population-based cohort study. Arthritis Rheum 2008 Aug; 58(8):2268-74.
    View PubMed
28. Melton LJ 3rd, Leibson CL, Achenbach SJ, Therneau TM, Khosla S. Fracture risk in type 2 diabetes: update of a population-based study. J Bone Miner Res 2008 Aug; 23(8):1334-42.
    View PubMed
29. Maradit Kremers H, Crowson CS, Therneau TM, Roger VL, Gabriel SE. High ten-year risk of cardiovascular disease in newly diagnosed rheumatoid arthritis patients: a population-based cohort study. Arthritis & Rheumatism 2008 Aug; 58(8):2268-74.
    View PubMed
30. Gonzalez A, Icen M, Maradit Kremers H, Crowson CS, Davis JM, Therneau TM, Roger VL, Gabriel SE. Mortality trends in rheumatoid arthritis: The role of rheumatoid factor. J Rheumatol 2008 Jun; 35(6):1009-14.
    View PubMed
31. Gonzalez A, Icen M, Kremers HM, Crowson CS, Davis JM 3rd, Therneau TM, Roger VL, Gabriel SE. Mortality trends in rheumatoid arthritis: the role of rheumatoid factor. J Rheumatol 2008 Jun; 35(6):1009-14. Epub 2008 Apr 15.
    View PubMed
32. Gerber Y, Weston SA, Killian JM, Therneau TM, Jacobsen SJ, Roger VL. Neighborhood income and individual education: effect on survival after myocardial infarction. Mayo Clin Proc 2008 Jun; 83(6):663-9.
    View PubMed
33. Gonzalez A, Icen M, Kremers HM, Crowson CS, Davis JM III, Therneau TM, Roger VL, Gabriel SE. Mortality trends in rheumatoid arthritis: the role of rheumatoid factor. J Rheumatol 2008 Jun; 35(6):1009-14. Epub 2008-04-15.
    View PubMed
34. Mendes FD, Kim WR, Pedersen R, Therneau T, Lindor KD. Mortality attributalbe to cholestatic liver disease in the United States Hepatology 2008 Apr.
    View PubMed
35. Mendes FD, Kim WR, Pedersen R, Therneau T, Lindor KD. Mortality attributable to cholestatic liver disease in the United States. Hepatology 2008 Apr; 47(4):1241-7.
    View PubMed
36. Therneau TM. Memories of Sam Wieand. Lifetime Data Anal 2008 Mar; 14(1):13-5. Epub 2007 Dec 12.
    View PubMed
37. Lee TH, Kim WR, Benson JT, Therneau TM, Melton LJ 3rd. Serum aminotransferase activity and mortality risk in a United States community. Hepatology 2008 Mar; 47(3):880-7.
    View PubMed
38. Dispenzieri A, Kyle RA, Katzmann JA, Therneau TM, Larson D, Benson J, Clark RJ, Melton LJ 3rd, Gertz MA, Kumar SK, Fonseca R, Jelinek DF, Rajkumar SV. Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma. Blood 2008 Jan 15; 111(2):785-9. Epub 2007 Oct 17.
    View PubMed
39. Oberg AL, Mahoney DW, Eckel-Passow JE, Malone CJ, Wolfinger RD, Hill EG, Cooper LT, Onuma OK, Spiro C, Therneau TM, Bergen III HR. Statistical analysis of relative labeled mass spectrometry data from complex samples using ANOVA. J Proteome Res 2008 Jan; 7(1):225-33 Epub 2008 Jan 4.
    View PubMed
40. Oberg AL, Mahoney DW, Eckel-Passow JE, Malone CJ, Wolfinger RD, Hill EG, Cooper LT, Onuma OK, Spiro C, Therneau TM, Bergen III HR. Statistical analysis of relative labeled mass spectrometry data from complex samples using ANOVA J Proteome Res 2008 Jan; 7(1):225-33.
    View PubMed
41. Oberg AL, Mahoney DW, Eckel-Passow JE, Malone CJ, Wolfinger RD, Hill EG, Cooper LT, Onuma OK, Spiro C, Therneau TM, Bergen HR 3rd. Statistical analysis of relative labeled mass spectrometry data from complex samples using ANOVA. J Proteome Res 2008 Jan; 7(1):225-33. Epub 2008 Jan 04.
    View PubMed
42. Therneau TM, Ballman KV. What Does PLIER Really Do? Cancer Inform 2008; 6:423-31. Epub 2008 Aug 27.
    View PubMed
43. Gonzalez A, Maradit Kremers H, Crowson CS, Nicola PJ, Davis JM 3rd, Therneau TM, Roger VL, Gabriel SE. The widening mortality gap between rheumatoid arthritis patients and the general population. Arthritis Rheum 2007 Nov; 56(11):3583-7.
    View PubMed
44. Gerber Y, Rihal CS, Sundt TM 3rd, Killian JM, Weston SA, Therneau TM, Roger VL. Coronary revascularization in the community. A population-based study, 1990 to 2004. J Am Coll Cardiol 2007 Sep 25; 50(13):1223-9. Epub 2007 Sep 10.
    View PubMed
45. Gandy A, Therneau TM, Aalen OO. Global tests in the additive hazards regression model. Stat Med. Epub ahead of print. 2007 Jun 26.
    View PubMed
46. Kyle RA, Remstein ED, Therneau TM, Dispenzieri A, Kurtin PJ, Hodnefield JM, Larson DR, Plevak MF, Jelinek DF, Fonseca R, Melton LJ 3rd, Rajkumar SV. Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma. N Engl J Med 2007 Jun 21; 356(25):2582-90.
    View PubMed
47. Vasmatzis G, Klee EW, Kube DM, Therneau TM, Kosari F. Quantitating tissue specificity of human genes to facilitate biomarker discovery. Bioinformatics 2007 Jun 1; 23(11):1348-55. Epub 2007 Mar 23.
    View PubMed
48. Angulo P, Hui JM, Marchesini G, Bugianesi E, George J, Farrell GC, Enders F, Saksena S, Burt AD, Bida JP, Lindor K, Sanderson SO, Lenzi M, Adams LA, Kench J, Therneau TM, Day CP. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology 2007 Apr; 45(4):846-54.
    View PubMed
49. Teh SH, Nagorney DM, Stevens SR, Offord KP, Therneau TM, Plevak DJ, Talwalkar JA, Kim WR, Kamath PS. Risk factors for mortality after surgery in patients with cirrhosis. Gastroenterology 2007 Apr; 132(4):1261-9.
    View PubMed
50. Chen J, Yu K, Hsing A, Therneau TM. A partially linear tree-based regression model for assessing complex joint gene-gene and gene-environment effects. Genet Epidemiol 2007 Apr; 31(3):238-51.
    View PubMed
51. Davis JM 3rd, Maradit Kremers H, Crowson CS, Nicola PJ, Ballman KV, Therneau TM, Roger VL, Gabriel SE. Glucocorticoids and cardiovascular events in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum 2007 Mar; 56(3):820-30.
    View PubMed
52. Leerapun A, Suravarapu SV, Bida JP, Clark RJ, Sanders EL, Mettler TA, Stadheim LM, Aderca I, Moser CD, Nagorney DM, LaRusso NF, de Groen PC, Menon KV, Lazaridis KN, Gores GJ, Charlton MR, Roberts RO, Therneau TM, Katzmann JA, Roberts LR. The utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: evaluation in a United States referral population. Clin Gastroenterol Hepatol 2007 Mar; 5(3):394-402; quiz 267.
    View PubMed
53. Crowson CS, Therneau TM, Matteson EL, Gabriel SE. Primer: Demystifying risk--understanding and communicating medical risks. Nat Clin Pract Rheumatol 2007 Mar; 3(3):181-7; quiz 1 p following 187.
    View PubMed
54. Mason CJ, Therneau TM, Eckel-Passow JE, Johnson KL, Oberg AL, Olson JE, Nair KS, Muddiman DC, Bergen HR 3rd. A method for automatically interpreting mass spectra of 18O-labeled isotopic clusters. Mol Cell Proteomics 2007 Feb; 6(2):305-18.
    View PubMed
55. Gerber Y, Rihal CS, Sundt TM, Killian JM, Weston SA, Therneau TM, Roger VL. Coronary revascularization in the community: A population-based study 1990-2004 J Am Coll Cardiol in press 2007.
    View PubMed
56. Balan V, Aravind L, Grill DE, Therneau TM, Sulkowski MS, Nelson DR, Praestgaard J, Rosati M, Birse CE, Moore PA, Mani Subramanian G. Global transcriptional effects of PEG-IFN-alpha and ribavirin on peripheral blood cells obtained from patients with chronic hepatitis C. Hepatol Res 2006 Dec; 36(4):277-87. Epub 2006 Oct 09.
    View PubMed
57. Balan V, Aravind L, Grill DE, Therneau TM, Sulkowski MS, Nelson DR, Praestgaard J, Rosati M, Birse CE, Moore PA, Mani Subramanian G. Global transcriptional effects of PEG-IFN-alpha and ribavirin on peripheral blood cells obtained from patients with chronic hepatitis C. Hepatol Res 2006 Dec; 36(4):277-87. Epub 2006-10-09.
    View PubMed
58. Eckel-Passow JE, Oberg AL, Therneau TM, Mason CJ, Mahoney DW, Johnson KL, Olson JE, Bergen HR 3rd. Regression analysis for comparing protein samples with 16O/18O stable-isotope labeled mass spectrometry. Bioinformatics 2006 Nov 15; 22(22):2739-45. Epub 2006 Sep 05.
    View PubMed
59. Balan V, Arawind L, Grill DE, Therneau TM, Sulkowski MS, Nelson DR, Praestgaard J, Rosati M, Birse CE, Moore PA, Mani Subramanian G. Global transcriptional effects of PEG-IFN-alpha and ribavirin on peripheral blood cells obtained from patients with chronic hepatitis C. Hepatol Res Epub 2006 Oct 9; 36(4):277-87.
    View PubMed
60. Oberg AL, Mahoney DW, Ballman KV, Therneau TM. Joint estimation of calibration and expression for high-density oligonucleotide arrays. Bioinformatics 2006 Oct 1; 22(19):2381-7. Epub 2006 Jul 28.
    View PubMed
61. Dingli D, Kyle RA, Rajkumar SV, Nowakowski GS, Larson DR, Bida JP, Gertz MA, Therneau TM, Melton LJ 3rd, Dispenzieri A, Katzmann JA. Immunoglobulin free light chains and solitary plasmacytoma of bone. Blood 2006 Sep 15; 108(6):1979-83. Epub 2006 Jun 01.
    View PubMed
62. Biggins SW, Kim WR, Terrault NA, Saab S, Balan V, Schiano T, Benson J, Therneau T, Kremers W, Wiesner R, Kamath P, Klintmalm G. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology 2006 May; 130(6):1652-60.
    View PubMed
63. Ghobrial IM, Fonseca R, Gertz MA, Plevak MF, Larson DR, Therneau TM, Wolf RC, Hoffmann RJ, Lust JA, Witzig TE, Lacy MQ, Dispenzieri A, Rajkumar SV, Zeldenrust SR, Greipp PR, Kyle RA. Prognostic model for disease-specific and overall mortality in newly diagnosed symptomatic patients with Waldenstrom macroglobulinaemia. Br J Haematol 2006 Apr; 133(2):158-64.
    View PubMed
64. Ghobrial IM, Fonseca R, Gertz MA, Plevak MF, Larson DR, Therneau TM, Wolf RC, Hoffmann RJ, Lust JA, Witzig TE, Lacy MQ, Dispenzieri A, Vincent Rajkumar S, Zeldenrust SR, Greipp PR, Kyle RA. Prognostic model for disease-specific and overall mortality in newly diagnosed symptomatic patients with Waldenstrom macroglobulinaemia. Br J Haematol 2006 Apr; 133(2):158-64.
    View PubMed
65. Kyle RA, Therneau TM, Rajkumar SV, Larson DR, Plevak MF, Offord JR, Dispenzieri A, Katzmann JA, Melton LJ 3rd. Prevalence of monoclonal gammopathy of undetermined significance. N Engl J Med 2006 Mar 30; 354(13):1362-9.
    View PubMed
66. Kim WR, Therneau TM, Benson JT, Kremers WK, Rosen CB, Gores GJ, Dickson ER. Deaths on the liver transplant waiting list: an analysis of competing risks. Hepatology 2006 Feb; 43(2):345-51.
    View PubMed
67. Vachon CM, Sellers TA, Janney CA, Brandt KR, Carlson EE, Pankratz VS, Wu FF, Therneau TM, Cerhan JR. Alcohol intake in adolescence and mammographic density. Int J Cancer 2005 Dec 10; 117(5):837-41.
    View PubMed
68. Dewald GW, Therneau T, Larson D, Lee YK, Fink S, Smoley S, Paternoster S, Adeyinka A, Ketterling R, Van Dyke DL, Fonseca R, Kyle R. Relationship of patient survival and chromosome anomalies detected in metaphase and/or interphase cells at diagnosis of myeloma. Blood 2005 Nov 15; 106(10):3553-8.
    View PubMed
69. Crowson CS, Nicola PJ, Maradit Kremers H, O'Fallon WM, Therneau TM, Jacobsen SJ, Roger VL, Ballman KV, Gabriel SE. How much of the increased incidence of heart failure in rheumatoid arthritis is attributable to traditional cardiovascular risk factors and ischemic heart disease? Arthritis Rheum 2005 Oct; 52(10):3039-44.
    View PubMed
70. Rajkumar SV, Kyle RA, Therneau TM, Melton LJ 3rd, Bradwell AR, Clark RJ, Larson DR, Plevak MF, Dispenzieri A, Katzmann JA. Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance. Blood 2005 Aug 1; 106(3):812-7.
    View PubMed
71. Rongey C, Bambha K, Vanness D, Pedersen RA, Malinchoc M, Therneau TM, Dickson ER, Kim WR. Employment and health insurance in long-term liver transplant recipients. Am J Transplant 2005 Aug; 5(8):1901-8.
    View PubMed
72. Kim WR, Gores GJ, Benson JT, Therneau TM, Melton LJ 3rd. Mortality and hospital utilization for hepatocellular carcinoma in the United States. Gastroenterology 2005 Aug; 129(2):486-93.
    View PubMed
73. Palladini G, Kyle RA, Larson DR, Therneau TM, Merlini G, Gertz MA. Multicentre versus single centre approach to rare diseases: The model of systemic light chain amyloidosis. Amyloid 2005 Jun; 12(2):120-6.
    View PubMed
74. Eckel-Passow JE, Hoering A, Therneau TM, Ghobrial I. Experimental design and analysis of antibody microarrays: applying methods from cDNA arrays. Cancer Res 2005 Apr 15; 65(8):2985-9.
    View PubMed
75. Eckel JE, Gennings C, Therneau TM, Burgoon LD, Boverhof DR, Zacharewski TR. Normalization of two-channel microarray experiments: a semiparametric approach. Bioinformatics 2005 Apr 1; 21(7):1078-83.
    View PubMed
76. Kyle RA, Rajkumar SV, Therneau TM, Larson DR, Plevak MF, Melton LJ 3rd. Prognostic factors and predictors of outcome of immunoglobulin M monoclonal gammopathy of undetermined significance. Clin Lymphoma 2005 Mar; 5(4):257-60.
    View PubMed
77. Pankratz VS, de Andrade M, Therneau TM. Random-effects cox proportional hazards model: General variance components methods for time-to-event data. Genet Epidemiol 2005 Feb; 28(2):97-109.
    View PubMed
78. Kyle RA, Therneau TM, Rajkumar SV, Larson DR, Plevak MF, Melton LJ. Incidence of multiple myeloma in Olmsted County, Minnesota - Trend over 6 decades. Cancer 2004 Dec 1; 101(11):2667-74.
    View PubMed
79. Ballman KV, Grill DE, Oberg AL, Therneau TM. Faster cyclic loess: normalizing RNA arrays via linear models. Bioinformatics 2004 Nov 1; 20(16):2778-86.
    View PubMed
80. Rajkumar SV, Kyle RA, Therneau TM, Clark RJ, Bradwell AR, Melton LJ, Larson DR, Plevak MF, Katzmann JA. Presence of monoclonal free light chains in the serum predicts risk of progression in monoclonal gammopathy of undetermined significance. Br J Haematol 2004 Nov; 127(3):308-10.
    View PubMed
81. Bambha K, Kim WR, Kremers WK, Therneau TM, Kamath PS, Wiesner R, Rosen CB, Thostenson J, Benson JT, Dickson ER. Predicting survival among patients listed for liver transplantation: An assessment of serial MELD measurements. Am J Transplant 2004 Nov; 4(11):1798-804.
    View PubMed
82. Dispenzieri A, Gertz MA, Kyle RA, Lacy MQ, Burritt MF, Therneau TM, Greipp PR, Witzig TE, Lust JA, Rajkumar SV, Fonseca R, Zeldenrust SR, McGregor CG, Jaffe AS. Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis. J Clin Oncol 2004 Sep 15; 22(18):3751-7.
    View PubMed
83. Dispenzieri A, Gertz MA, Kyle RA, Lacy MQ, Burritt MF, Therneau TM, McConnell JP, Litzow MR, Gastineau DA, Tefferi A, Inwards DJ, Micallef IN, Ansell SM, Porrata LF, Elliott MA, Hogan WJ, Rajkumar SV, Fonseca R, Greipp PR, Witzig TE, Lust JA, Zeldenrust S Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation. Blood 2004 Sep 15; 104(6):1881-7.
    View PubMed
84. Kim WR, Poterucha JJ, Benson JT, Therneau TM. The impact of competing risks on the observed rate of chronic hepatitis C progression. Gastroenterology 2004 Sep; 127(3):749-55.
    View PubMed
85. Kipp BR, Stadheim LM, Halling SA, Pochron NL, Harmsen S, Nagorney DM, Sebo TJ, Therneau TM, Gores GJ, de Groen PC, Baron TH, Levy MJ, Halling KC, Roberts LR. A comparison of routine cytology and fluorescence in situ hybridization for the detection of malignant bile duct strictures. Am J Gastroenterol 2004 Sep; 99(9):1675-81.
    View PubMed
86. Kyle RA, Therneau TM, Rajkumar SV, Larson DR, Plevak MF, Melton LJ. Long-term follow-up of 241 patients with monoclonal Gammopathy of undetermined significance: The original Mayo clinic series 25 years later. Mayo Clin Proc 2004 Jul; 79(7):859-66.
    View PubMed
87. Kumar SK, Therneau TM, Gertz MA, Lacy MQ, Dispenzieri A, Rajkumar SV, Fonseca R, Witzig TE, Lust JA, Larson DR, Kyle RA, Greipp PR. Clinical course of patients with relapsed multiple myeloma. Mayo Clin Proc 2004 Jul; 79(7):867-74.
    View PubMed
88. Dispenzieri A, Kyle RA, Lacy MQ, Therneau TM, Larson DR, Plevak MF, Rajkumar SV, Fonseca R, Greipp PR, Witzig TE, Lust JA, Zeldenrust SR, Snow DS, Hayman SR, Litzow MR, Gastineau DA, Tefferi A, Inwards DJ, Micallef IN, Ansell SM, Porrata LF, Elliott MA, Superior survival in primary systemic amyloidosis patients undergoing peripheral blood stem cell transplantation: a case-control study. Blood 2004 May 15; 103(10):3960-3.
    View PubMed
89. Baron TH, Harewood GC, Rumalla A, Pochron NL, Stadheim LM, Gores GJ, Therneau TM, de Groen PC, Sebo TJ, Salomao DR, Kipp BR. A prospective comparison of digital image analysis and routine cytology for the identification of malignancy in biliary tract strictures. Clinical Gastroenterology & Hepatology 2004 Mar; 2(3):214-9.
    View PubMed
90. Kim WR, Benson JT, Therneau TM, Torgerson HA, Yawn BP, Melton LJ. Changing epidemiology of hepatitis B in a US community. Hepatology 2004 Mar; 39(3):811-6.
    View PubMed
91. Kyle RA, Therneau TM, Rajkumar SV, Remstein ED, Offord JR, Larson DR, Plevak MF, Melton LJ. Long-term follow-up of IgM monoclonal gammopathy of undetermined significance. Blood 2003 Nov 15; 102(10):3759-64.
    View PubMed
92. Bambha K, Kim WR, Talwalkar J, Torgerson H, Benson JT, Therneau TM, Loftus EV, Yawn BP, Dickson ER, Melton LJ. Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community. Gastroenterology 2003 Nov; 125(5):1364-9.
    View PubMed
93. Ghobrial IM, Dispenzieri A, Bundy KL, Gastineau DA, Rajkumar SV, Therneau TM, Lacy MQ, Witzig TE, Litzow MR, Christensen BR, Hayman S, Pribula CG, Gertz MA. Effect of thalidomide on stem cell collection and engraftment in patients with multiple myeloma. Bone Marrow Transplant 2003 Sep; 32(6):587-92.
    View PubMed
94. Youdas JW, Krause DA, Egan KS, Therneau TM, Laskowski ER. The effect of static stretching of the calf muscle-tendon unit on active ankle dorsiflexion range of motion. Journal of Orthopaedic & Sports Physical Therapy 2003 Jul; 33(7):408-17.
    View PubMed
95. Dispenzieri A, Kyle RA, Gertz MA, Therneau TM, Miller WL, Chandrasekaran K, McConnell JP, Burritt MF, Jaffe AS. Survival in patients with primary systemic amyloidosis and raised serum cardiac troponins. Lancet 2003 May 24; 361(9371):1787-9.
    View PubMed
96. Dispenzieri A, Kyle RA, Lacy MQ, Rajkumar SV, Therneau TM, Larson DR, Greipp PR, Witzig TE, Basu R, Suarez GA, Fonseca R, Lust JA, Gertz MA. POEMS syndrome: definitions and long-term outcome. Blood 2003 Apr 1; 101(7):2496-506.
    View PubMed
97. Kyle RA, Therneau TM, Rajkumar SV, Offord JR, Larson DR, Plevak MF, Melton LJ. Long-term follow-up of IgM monoclonal gammopathy of undetermined significance. Semin Oncol 2003 Apr; 30(2):169-71.
    View PubMed
98. Therneau TM, Grambsch PM, Pankratz VS. Penalized survival models and frailty. Journal of Computational and Graphical Statistics 2003 Mar; 12(1):156-75.
99. Kyle RA, Gertz MA, Witzig TE, Lust JA, Lacy MQ, Dispenzieri A, Fonseca R, Rajkumar SV, Offord JR, Larson DR, Plevak ME, Therneau TM, Greipp PR. Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc 2003 Jan; 78(1):21-33.
    View PubMed
100. Grabrick DM, Cerhan JR, Vierkant RA, Therneau TM, Cheville JC, Tindall DJ, Sellers TA. Evaluation of familial clustering of breast and prostate cancer in the Minnesota Breast Cancer Family Study. Cancer Detect Prev 2003; 27(1):30-6.
     View PubMed
101. Rajkumar SV, Kyle RA, Plevak MF, Murray JA, Therneau TM. Helicobacter pylori infection and monoclonal gammopathy of undetermined significance. Br J Haematol 2002 Dec; 119(3):706-8.
     View PubMed
102. Therneau T, Tschumper RC, Jelinek D. Sharpening spots: correcting for bleedover in cDNA array images. Math Biosci 2002 Mar; 176(1):1-15.
     View PubMed
103. Kyle RA, Therneau TM, Rajkumar SV, Offord JR, Larson DR, Plevak MF, Melton L. A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med 2002 Feb 21; 346(8):564-9.
     View PubMed
104. Rajkumar SV, Fonseca R, Dispenzieri A, Lacy MQ, Lust JA, Witzig TE, Therneau TM, Kyle RA, Greipp PR, Gertz MA. Methods for estimation of bone marrow plasma cell involvement in myeloma: Predictive value for response and survival in patients undergoing autologous stem cell transplantation. Am J Hematol 2001 Dec; 68(4):269-75.
     View PubMed
105. Dispenzieri A, Lacy MQ, Kyle RA, Therneau TM, Larson DR, Rajkumar SV, Fonseca R, Greipp PR, Witzig TE, Lust JA, Gertz MA. Eligibility for hematopoietic stem-cell transplantation for primary systemic amyloidosis is a favorable prognostic factor for survival. J Clin Oncol 2001 Jul 15; 19(14):3350-6.
     View PubMed
106. Sellers TA, Kushi LH, Cerhan JR, Vierkant A, Gapstur, Vachon CM, Olson JE, Therneau TM, Folsom AR. Dietary folate intake, alchohol and risk of breast cancer in a prospective study of postmenopausal women. Epidemiology 2001 Jul; 12(4):420-8.
     View PubMed
107. Sellers TA, Kushi LH, Cerhan JR, Vierkant RA, Gapstur SM, Vachon CM, Olson JE, Therneau TM, Folsom AR. Dietary folate intake, alcohol, and risk of breast cancer in a prospective study of postmenopausal women. Epidemiology 2001 Jul; 12(4):420-428.
     View PubMed
108. Dispenzieri A, Gertz MA, Therneau TM, Kyle RA. Retrospective cohort study of 148 patients with polyclonal gammopathy. Mayo Clin Proc 2001 May; 76(5):476-87.
     View PubMed
109. Steensma DP, Gertz MA, Greipp PR, Kyle RA, Lacy MQ, Lust JA, Offord JR, Plevak MF, Therneau TM, Witzig TE. A high bone marrow plasma cell labeling index in stable plateau-phase multiple myeloma is a marker for early disease progression and death. Blood 2001 Apr 15; 97(8):2522-3.
     View PubMed
110. Couch FJ, Cerhan JR, Vierkant RA, Grabrick DM, Therneau TM, Pankratz VS, Hartmann LC, Olson JE, Vachon CM, Sellers TA. Cigarette smoking increases risk for breast cancer in high-risk breast cancer families. Cancer Epidemiol Biomarkers Prev 2001 Apr; 10(4):327-32.
     View PubMed
111. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, D'Amico G, Dickson ER, Kim WR. A model to predict survival in patients with end-stage liver disease. Hepatology 2001 Feb; 33(2):464-70.
     View PubMed
112. Rumalla A, Baron TH, Leontovich O, Burgart LJ, Yacavone RF, Therneau TM, de Groen PC, Sebo TJ. Improved diagnostic yield of endoscopic biliary brush cytology by digital image analysis. Mayo Clin Proc 2001 Jan; 76(1):29-33.
     View PubMed
113. Kim WR, Lindor KD, Locke GR 3rd, Therneau TM, Homburger HA, Batts KP, Yawn BP, Petz JL, Melton LJ 3rd, Dickson ER. Epidemiology and natural history of primary biliary cirrhosis in a US community. Gastroenterology 2000 Dec; 119(6):1631-6.
     View PubMed
114. Figueiredo F, Dickson ER, Pasha T, Kasparova P, Therneau T, Malinchoc M, DiCecco S, Francisco-Ziller N, Charlton M. Impact of nutritional status on outcomes after liver transplantation. Transplantation 2000 Nov 15; 70(9):1347-52.
     View PubMed
115. Kovtun IV, Therneau TM, McMurray CT. Gender of the embryo contributes to CAG instability in transgenic mice containing a Huntington's disease gene. Hum Mol Genet 2000 Nov 1; 9(18):2767-75.
     View PubMed
116. Angulo P, Patel T, Jorgensen RA, Therneau TM, Lindor KD. Silymarin in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid. Hepatology 2000 Nov; 32(5):897-900.
     View PubMed
117. Rajkumar SV, Fonseca R, Dispenzieri A, Lacy MQ, Witzig TE, Lust JA, Larson D, Therneau TM, Kyle RA, Litzow MR, Greipp PR, Gertz MA. Effect of complete response on outcome following autologous stem cell transplantation for myeloma. Bone Marrow Transplant 2000 Nov; 26(9):979-83.
     View PubMed
118. Sorbi D, McGill DB, Thistle JL, Therneau TM, Henry J, Lindor KD. An assessment of the role of liver biopsies in asymptomatic patients with chronic liver test abnormalities. Am J Gastroenterol 2000 Nov; 95(11):3206-10.
     View PubMed
119. Grabrick DM, Hartmann LC, Cerhan JR, Vierkant RA, Therneau TM, Vachon CM, Olson JE, Couch FJ, Anderson KE, Pankratz VS, Sellers TA. Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer. JAMA 2000 Oct 11; 284(14):1791-8.
     View PubMed
120. Figueiredo FA, Dickson ER, Pasha TM, Porayko MK, Therneau TM, Malinchoc M, DiCecco SR, Francisco-Ziller NM, Kasparova P, Charlton MR. Utility of standard nutritional parameters in detecting body cell mass depletion in patients with end-stage liver disease. Liver Transpl 2000 Sep; 6(5):575-81.
     View PubMed
121. Krowka MJ, Wiseman GA, Burnett OL, Spivey JR, Therneau T, Porayko MK, Wiesner RH. Hepatopulmonary syndrome - a prospective study of relationships between severity of liver disease, PAO(2) response to 100% oxygen, and brain uptake after Tc-99m MAA lung scanning. Chest 2000 Sep; 118(3):615-624.
     View PubMed
122. Brandhagen DJ, Gross JB Jr, Poterucha JJ, Germer JJ, Czaja AJ, Smith CI, Ribeiro AC, Guerrero RB, Therneau TM, Schiff E, Gordon FD, Wiesner RH, Persing DH. Human leukocyte antigen DR markers as predictors of progression to liver transplantation in patients with chronic hepatitis C. Am J Gastroenterol 2000 Aug; 95(8):2056-60.
     View PubMed
123. Witzig TE, Meyers C, Therneau T, Greipp PR. A prospective study of CD38/45 flow cytometry and immunofluorescence microscopy to detect blood plasma cells in patients with plasma cell proliferative disorders. Leukemia & Lymphoma 2000 Jul; 38(3-4):345-50.
     View PubMed
124. Kim WR, Therneau TM, Wiesner RH, Poterucha JJ, Benson JT, Malinchoc M, LaRusso NF, Lindor KD, Dickson ER. A revised natural history model for primary sclerosing cholangitis. Mayo Clin Proc 2000 Jul; 75(7):688-94.
     View PubMed
125. Kim WR, Wiesner RH, Poterucha JJ, Therneau TM, Benson JT, Krom RA, Dickson ER. Adaptation of the Mayo primary biliary cirrhosis natural history model for application in liver transplant candidates. Liver Transpl 2000 Jul; 6(4):489-94.
     View PubMed
126. Youdas JW, Atwood AL, Harris-Love MO, Stiller TL, Egan KS, Therneau TM. Measurements of temporal aspects of gait obtained with a multimemory stopwatch in persons with gait impairments. J Orthop Sports Phys Ther 2000 May; 30(5):279-86.
     View PubMed
127. Kyle RA, Greipp PR, Gertz MA, Witzig TE, Lust JA, Lacy MQ, Therneau TM. Waldenstrom's macroglobulinemia: a prospective study comparing daily with intermittent oral chlorambucil. Br J Haematol 2000 Mar; 108(4):737-42.
     View PubMed
128. Cleavinger PJ, Persing DH, Li H, Moore SB, Charlton MR, Sievers C, Therneau TM, Zein NN. Prevalence of TT virus infection in blood donors with elevated ALT in the absence of known hepatitis markers. Am J Gastroenterol 2000 Mar; 95(3):772-6.
     View PubMed
129. Youdas JW, Garrett TR, Egan KS, Therneau TM. Lumbar lordosis and pelvic inclination in adults with chronic low back pain. Phys Ther 2000 Mar; 80(3):261-75.
     View PubMed
130. Brandhagen DJ, Alvarez W, Therneau TM, Kruckeberg KE, Thibodeau SN, Ludwig J, Porayko MK. Iron overload in cirrhosis-HFE genotypes and outcome after liver transplantation. Hepatology 2000 Feb; 31(2):456-60.
     View PubMed
131. Vierkant RA, Therneau TM, Kosanke JL, Naessens JM. MCSTRAT: A SAS Macro to analyze data from a matched or finely stratified case-control design. Technical Report Series Department of Health Sciences Research, Mayo Clinic, Rochester, MN 2000(Number 65).
132. Vierkant RA, Therneau TM, Kosanke JL, Naesens JM. A SAS Maco Analyze Data from a Matched or Finely Stratified Case-Control Design. Technical Report Series Number 65, Department of Health Sciences Research, Mayo Clinic, Rochester, MN 2000 2000.
133. Sellers TA, King RA, Cerhan JR, Chen PL, Grabrick DM, Kushi LH, Oetting WS, Vierkant RA, Vachon CM, Couch FJ, Therneau TM, Olson JE, Pankratz VS, Hartmann LC, Anderson VE. Fifty-year follow-up of cancer incidence in a historical cohort of Minnesota breast cancer families. Cancer Epidemiol Biomarkers Prev 1999 Dec; 8(12):1051-7.
     View PubMed
134. Angulo P, Larson DR, Therneau TM, LaRusso NF, Batts KP, Lindor KD. Time course of histological progression in primary sclerosing cholangitis. Am J Gastroenterol 1999 Nov; 94(11):3310-3.
     View PubMed
135. Zein NN, Arslan M, Li H, Charlton MR, Gross JB Jr, Poterucha JJ, Therneau TM, Kolbert CP, Persing DH. Clinical significance of TT virus infection in patients with chronic hepatitis C. Am J Gastroenterol 1999 Oct; 94(10):3020-7.
     View PubMed
136. Sabers SR, Kokal JE, Girardi JC, Philpott CL, Basford JR, Therneau TM, Schmidt KD, Gamble GL. Evaluation of consultation-based rehabilitation for hospitalized cancer patients with functional impairment. Mayo Clin Proc 1999 Sep; 74(9):855-61.
     View PubMed
137. Rajkumar S, Fonseca R, Lacy M, Witzig T, Lust J, Greipp P, Therneau T, Kyle R, Litzow M, Gertz M. Abnormal cytogenetics predict poor survival after high-dose therapy and autologous blood cell transplantation in multiple myeloma. Bone Marrow Transplant 1999 Sep; 24(5):497-503.
     View PubMed
138. Winemiller MH, Stolp-Smith KA, Silverstein MD, Therneau TM. Sequential Pneumatic Compression or Heparin is Effective in Preventing Venous Thromboembolism in Spinal Cord Injury Patients. Journal of Spinal Cord Medicine 1999 Fall; 22:182-19.
     View PubMed
139. Winemiller MH, Stolp-Smith KA, Silverstein MD, Therneau TM. Prevention of venous thromboembolism in patients with spinal cord injury: effects of sequential pneumatic compression and heparin. J Spinal Cord Med 1999 Fall; 22(3):182-91.
     View PubMed
140. Ansell SM, Kurtin PJ, Stenson M, Habermann TM, Greipp PR, Therneau TM, Witzig TE. Evaluation of the proliferative index as a prognostic factor in diffuse large cell lymphoma: correlation with the International Index. Leukemia & Lymphoma 1999 Aug; 34(5-6):529-37.
     View PubMed
141. Kim WR, Wiesner RH, Poterucha JJ, Therneau TM, Malinchoc M, Benson JT, Crippin JS, Klintmalm GB, Rakela J, Starzl TE, Krom RA, Evans RW, Dickson ER. Hepatic retransplantation in cholestatic liver disease: impact of the interval to retransplantation on survival and resource utilization. Hepatology 1999 Aug; 30(2):395-400.
     View PubMed
142. Rajkumar SV, Fonseca R, Dewald GW, Therneau TM, Lacy MQ, Kyle RA, Greipp PR, Gertz MA. Cytogenetic abnormalities correlate with the plasma cell labeling index and extent of bone marrow involvement in myeloma. Cancer Genetics & Cytogenetics 1999 Aug; 113(1):73-7.
     View PubMed
143. Therneau TM, Li H. Computing the Cox model for case cohort designs. Lifetime Data Anal 1999 Jun; 5(2):99-112.
     View PubMed
144. Kim WR, Poterucha JJ, Wiesner RH, LaRusso NF, Lindor KD, Petz J, Therneau TM, Malinchoc M, Dickson ER. The relative role of the Child-Pugh classification and the Mayo natural history model in the assessment of survival in patients with primary sclerosing cholangitis. Hepatology 1999 Jun; 29(6):1643-8.
     View PubMed
145. Rajkumar SV, Fonseca R, Lacy MQ, Witzig TE, Lust JA, Greipp PR, Therneau TM, Kyle RA, Litzow MR, Gertz MA. Beta(2)-microglobulin and bone marrow plasma cell involvement predict complete responders among patients undergoing blood cell transplantation for myeloma. Bone Marrow Transplant 1999 Jun; 23(12):1261-1266.
     View PubMed
146. Rajkumar SV, Fonseca R, Lacy MQ, Witzig TE, Lust JA, Greipp PR, Therneau TM, Kyle RA, Litzow MR, Gertz MA. Autologous stem cell transplantation for relapsed and primary refractory myeloma. Bone Marrow Transplant 1999 Jun; 23(12):1267-72.
     View PubMed
147. Nijhawan PK, Therneau TM, Dickson ER, Boynton J, Lindor KD. Incidence of cancer in primary biliary cirrhosis: the Mayo experience. Hepatology 1999 May; 29(5):1396-8.
     View PubMed
148. Georgiopoulos AM, Bryan TL, Yawn BP, Houston MS, Rummans TA, Therneau TM. Population-based screening for postpartum depression. Obstet Gynecol 1999 May; 93(5 Pt 1):653-7.
     View PubMed
149. Angulo P, Dickson ER, Therneau TM, Jorgensen RA, Smith C, DeSotel CK, Lange SM, Anderson ML, Mahoney DW, Lindor KD. Comparison of three doses of ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a randomized trial. J Hepatol 1999 May; 30(5):830-5.
     View PubMed
150. Rajkumar SV, Fonseca R, Lacy MQ, Witzig TE, Therneau TM, Kyle RA, Litzow MR, Gertz MA, Greipp PR. Plasmablastic morphology is an independent predictor of poor survival after autologous stem-cell transplantation for multiple myeloma. J Clin Oncol 1999 May; 17(5):1551-7.
     View PubMed
151. Angulo P, Lindor KD, Therneau TM, Jorgensen RA, Malinchoc M, Kamath PS, Dickson ER. Utilization of the Mayo risk score in patients with primary biliary cirrhosis receiving ursodeoxycholic acid. Liver 1999 Apr; 19(2):115-21.
     View PubMed
152. Angulo P, Batts KP, Therneau TM, Jorgensen RA, Dickson ER, Lindor KD. Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis. Hepatology 1999 Mar; 29(3):644-7.
     View PubMed
153. Kyle RA, Gertz MA, Greipp PR, Witzig TE, Lust JA, Lacy MQ, Therneau TM. Long-term survival (10 years or more) in 30 patients with primary amyloidosis. Blood 1999 Feb 1; 93(3):1062-6.
     View PubMed
154. Gross CR, Malinchoc M, Kim WR, Evans RW, Wiesner RH, Petz JL, Crippin JS, Klintmalm GB, Levy MF, Ricci P, Therneau TM, Dickson ER. Quality of life before and after liver transplantation for cholestatic liver disease. Hepatology 1999 Feb; 29(2):356-64.
     View PubMed
155. Witzig TE, Timm M, Larson D, Therneau T, Greipp PR. Measurement of apoptosis and proliferation of bone marrow plasma cells in patients with plasma cell proliferative disorders. Br J Haematol 1999 Jan; 104(1):131-7.
     View PubMed
156. Pasha T, Heathcote J, Gabriel S, Cauch-Dudek K, Jorgensen R, Therneau T, Dickson ER, Lindor KD. Cost-effectiveness of ursodeoxycholic acid therapy in primary biliary cirrhosis. Hepatology 1999 Jan; 29(1):21-6.
     View PubMed
157. Vierkant RA, Therneau TM, Kosanke JL, Naessens JM. A SAS macro to analyze data from a matched or timely stratfied case-control design. Proc 24th Ann SAS Users Group Inter 1999:1650-5.
158. Fonseca R, Ahmann GJ, Jalal SM, Dewald GW, Larson DR, Therneau TM, Gertz MA, Kyle RA, Greipp PR. Chromosomal abnormalities in systemic amyloidosis. Br J Haematol 1998 Dec; 103(3):704-10.
     View PubMed
159. Angulo P, Therneau TM, Jorgensen A, DeSotel CK, Egan KS, Dickson ER, Hay JE, Lindor KD. Bone disease in patients with primary sclerosing cholangitis: prevalence, severity and prediction of progression. J Hepatol 1998 Nov; 29(5):729-35.
     View PubMed
160. Graziadei IW, Joseph JJ, Wiesner RH, Therneau TM, Batts KP, Porayko MK. Increased risk of chronic liver failure in adults with heterozygous alpha (1)-antitrypsin deficiency. Hepatology 1998 Oct; 28(4):1058-1063.
     View PubMed
161. Witzig TE, Kimlinger T, Stenson M, Therneau T. Syndecan-1 expression on malignant cells from the blood and marrow of patients with plasma cell proliferative disorders and B-cell chronic lymphocytic leukemia. Leukemia & Lymphoma 1998 Sep; 31(1-2):167-75.
     View PubMed
162. Charlton M, Adjei P, Poterucha J, Zein N, Moore B, Therneau T, Krom R, Wiesner R. TT-virus infection in North American blood donors, patients with fulminant hepatic failure, and cryptogenic cirrhosis. Hepatology 1998 Sep; 28(3):839-42.
     View PubMed
163. Kim WR, Wiesner RH, Therneau TM, Poterucha JJ, Porayko MK, Evans RW, Klintmalm GB, Crippin JS, Krom RA, Dickson ER. Optimal timing of liver transplantation for primary biliary cirrhosis. Hepatology 1998 Jul; 28(1):33-8.
     View PubMed
164. Pasha T, Gabriel S, Therneau T, Dickson ER, Lindor KD. Cost-effectiveness of ultrasound-guided liver biopsy. Hepatology 1998 May; 27(5):1220-6.
     View PubMed
165. Melton LJ, Therneau TM, Larson DR. Long-term trends in hip fracture prevalence: the influence of hip fracture incidence and survival. Osteoporos Int 1998; 8(1):68-74.
     View PubMed
166. Lindor KD, Jorgensen RA, Therneau TM, Malinchoc M, Dickson ER. Ursodeoxycholic acid delays the onset of esophageal varices in primary biliary cirrhosis. Mayo Clin Proc 1997 Dec; 72(12):1137-40.
     View PubMed
167. Kim WR, Poterucha JJ, Hermans JE, Therneau TM, Dickson ER, Evans RW, Gross JB Jr. Cost-effectiveness of 6 and 12 months of interferon-alpha therapy for chronic hepatitis C. Ann Intern Med 1997 Nov 15; 127(10):866-74.
     View PubMed
168. Therneau TM, Hamilton SA. rhDNase as an example of recurrent event analysis. Stat Med 1997 Sep 30; 16(18):2029-47.
     View PubMed
169. van Dam GM, Verbaan BW, Therneau TM, Dickson ER, Malinchoc M, Murtaugh PA, Huizenga JR, Gips CH. Primary biliary cirrhosis: Dutch application of the Mayo Model before and after orthotopic liver transplantation. Hepatogastroenterology 1997 May-Jun; 44(15):732-43.
     View PubMed
170. Kyle RA, Gertz MA, Greipp PR, Witzig TE, Lust JA, Lacy MQ, Therneau TM. A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine. N Engl J Med 1997 Apr 24; 336(17):1202-7.
     View PubMed
171. Ricci P, Therneau TM, Malinchoc M, Benson JT, Petz JL, Klintmalm GB, Crippin JS, Wiesner RH, Steers JL, Rakela J, Starzl TE, Dickson ER. A prognostic model for the outcome of liver transplantation in patients with cholestatic liver disease. Hepatology 1997 Mar; 25(3):672-7.
     View PubMed
172. Van Norstrand MD, Malinchoc M, Lindor KD, Therneau TM, Gershwin ME, Leung PS, Dickson ER, Homburger HA. Quantitative measurement of autoantibodies to recombinant mitochondrial antigens in patients with primary biliary cirrhosis: relationship of levels of autoantibodies to disease progression. Hepatology 1997 Jan; 25(1):6-11.
     View PubMed
173. Nativ O, Umehara T, Colvard DS, Therneau TM, Farrow GM, Spelsberg TC, Lieber MM. Relationship between DNA ploidy and functional estrogen receptors in operable prostate cancer. Eur Urol 1997; 32(1):96-9.
     View PubMed
174. Therneau TM. Extending the Cox model. Proceedings of the First Seattle Symposium in Eds Lin DY and Felming, TR Springer-Verlag, New York, 51-84, 1997; Biostatistics:Survival Analysis.
175. Huang MS, Colby TV, Therneau TM, Daly RC, Gonchoroff NJ. DNA ploidy and protein content in bronchioloalveolar carcinoma multi-variable flow cytometry. Cytometry 1996 Dec 15; 26(4):253-9.
     View PubMed
176. Zein NN, Poterucha JJ, Gross JB Jr, Wiesner RH, Therneau TM, Gossard AA, Wendt NK, Mitchell PS, Germer JJ, Persing DH. Increased risk of hepatocellular carcinoma in patients infected with hepatitis C genotype 1b. Am J Gastroenterol 1996 Dec; 91(12):2560-2.
     View PubMed
177. Zein NN, Rakela J, Krawitt EL, Reddy KR, Tominaga T, Persing DH, Therneau TM, Gross JB, Poterucha JJ, Gossard AA, Jeffers LJ, Schiff ER. Hepatitis C virus genotypes in the United States: epidemiology, pathogenicity, and response to interferon therapy. Ann Intern Med 1996 Oct 15; 125(8):634-639.
     View PubMed
178. Billadeau D, Van Ness B, Kimlinger T, Kyle RA, Therneau TM, Greipp PR, Witzig TE. Clonal circulating cells are common in plasma cell proliferative disorders: a comparison of monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and active myeloma. Blood 1996 Jul 1; 88(1):289-96.
     View PubMed
179. Ludwig J, Hashimoto E, Porayko MK, Therneau TM. Failed allografts and causes of death after orthotopic liver transplantation from 1985 to 1995: decreasing prevalence of irreversible hepatic allograft rejection. Liver Transplantation & Surgery 1996 May; 2(3):185-91.
     View PubMed
180. Lindor KD, Therneau TM, Jorgensen RA, Malinchoc M, Dickson ER. Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosis. Gastroenterology 1996 May; 110(5):1515-8.
     View PubMed
181. Roberts SK, Therneau TM, Czaja AJ. Prognosis of histological cirrhosis in type 1 autoimmune hepatitis. Gastroenterology 1996 Mar; 110(3):848-57.
     View PubMed
182. Locke GR 3rd, Therneau TM, Ludwig J, Dickson ER, Lindor KD. Time course of histological progression in primary biliary cirrhosis. Hepatology 1996 Jan; 23(1):52-6.
     View PubMed
183. Grambsch PM, Therneau TM, Fleming TR. Diagnostic plots to reveal functional form for covariates in multiplicative intensity models. Biometrics 1995 Dec; 51(4):1469-82.
     View PubMed
184. Kim WR, Therneau TM, Dickson ER, Evans RW. Preoperative predictors of resource utilization in liver transplantation. Clin Transpl 1995; 315-22.
185. Grambsch PM, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 1994 Sep; 81:515-526.
186. Nativ O, Winkler HZ, Farrow GM, Therneau TM, Lieber MM. Clinical significance of nuclear DNA ploidy pattern in nonseminomatous germ cell testicular tumors. Urology 1994 Feb; 43(2):197-202.
     View PubMed
187. Therneau TM. How many stratification factors are "too many" to use in a randomization plan? Control Clin Trials 1993 Apr; 14(2):98-108.
     View PubMed
188. Oakes D, Moss AJ, Fleiss JL, Bigger JT Jr, Therneau TM, Eberly SW, McDermott MP, et al. Use of compliance measured in an analysis of the effect of diltiazem on mortality and reinfarction after myocardial infarction. J Amer Stat Assoc 1993; 88:44-9.
189. Laurie JA, Hahn RG, Therneau TM, Patel SR, Mailliard JA, Windschitl HE, Twito DI, Morton RF, Krook JE. Chermotherapy for hormonally refractory advanced prostate carcinoma. A comparison of combined versus sequential treatment with mitomycin C, doxorubicin, and 5-fluorouracil. Cancer 1992; 69:1440-4.
     View PubMed
190. Bajzer Z, Therneau TM, Sharp JC, Prendergast FG. Maximum likelihood method for the analysis of time-resolved fluorescence decay curves. Eur Biophys J 1991 Dec; 20:247-262.
191. Morton RF, Jett JR, McGinnis WL, Earle JD, Therneau TM, Krook JE, Elliott TE, Mailliard JA, Nelimark RA, Maksymiuk AW, et al. Thoracic radiation therapy alone compared with combined chemoradiotherapy for locally unresectable non-small cell lung cancer. A randomized, phase III trial. Ann Intern Med 1991 Nov 1; 115(9):681-6.
     View PubMed
192. Witzig TE, Gonchoroff NJ, Therneau T, Gilbertson DT, Wold LE, Grant C, Grande J, Katzmann JA, Ahmann DL, Ingle JN. DNA content flow cytometry as a prognostic factor for node-positive breast cancer: the role of multiparameter ploidy analysis and specimen sonication. Cancer 1991 Oct 15;68(8):1781-8.
193. Long HJ, Hauge MD, Therneau TM, Buckner JC, Frytak S, Hahn RG. Phase II evaluation of menogaril in patients with advanced hypernephroma. Invest New Drugs 1991 Aug; 9(3):261-2.
     View PubMed
194. Mahood DJ, Dose AM, Loprinzi CL, Veeder MH, Athmann LM, Therneau TM, Sorensen JM, Gainey DK, Mailliard JA, Gusa NL, Goldberg R. Inhibition of fluorouracil-induced stomatitis by oral cryotherapy. J Clin Oncol 1991 Mar;9(3):449-52.
     View PubMed
195. Goldberg RM, Jett JR, Therneau TM, Johnson PS, Tschetter LK, Krook JE, Veeder MH, Owen D, Etzell PS, Andres DF. Bolus versus infusion regimens of etoposide and cisplatin in treatment of non-small cell lung cancer: a study of the North Central Cancer Treatment group. J Natl Cancer Inst 1990 Dec 19; 82(24):1899-903.
     View PubMed
196. Tefferi A, Zellers RA, Banks PM, Therneau TM, Colgan JP. Clinical correlates of distinct immunophenotypic and histologic subcategories of lymphocyte-predominance Hodgkin's disease. J Clin Oncol 1990 Dec; 8(12):1959-65.
     View PubMed
197. Patel SR, Kvols LK, Hahn RG, Windschitl H, Levitt R, Therneau T. A phase II randomized trial of megestrol acetate or dexamethasone in the treatment of hormonally refractory advanced carcinoma of the prostate. Cancer 1990 Aug 15; 66(4):655-8.
     View PubMed
198. Nativ O, Myers RP, Farrow GM, Therneau TM, Zincke H, Lieber MM. Nuclear deoxyribonucleic acid ploidy and serum prostate specific antigen in operable prostatic adenocarcinoma. J Urol 1990 Aug; 144(2 Pt 1):303-6.
     View PubMed
199. Camoriano JK, Loprinzi CL, Ingle JN, Therneau TM, Krook JE, Veeder MH. Weight change in women treated with adjuvant therapy or observed following mastectomy for node-positive breast cancer. J Clin Oncol 1990 Aug; 8(8):1327-34.
     View PubMed
200. Loprinzi CL, Cianflone SG, Dose AM, Etzell PS, Burnham NL, Therneau TM, Hagen L, Gainey DK, Cross M, Athmann LM. A controlled evaluation of an allopurinol mouthwash as prophylaxis against 5-fluorouracil-induced stomatitis. Cancer 1990 Apr 15; 65(8):1879-82.
     View PubMed
201. Montgomery BT, Nativ O, Blute ML, Farrow GM, Myers RP, Zincke H, Therneau TM, Lieber MM. Stage three prostate adenocarcinoma: flow cytometric nuclear DNA ploidy analysis. Arch Surg 1990 Mar; 125:327-331.
     View PubMed
202. Jett JR, Everson L, Therneau TM, Krook JE, Dalton RJ, Marschke RF, Veeder MH, Brunk SF, Mailliard JA, Twito DI, the North Central Cancer Treatment Group. Treatment of limited-stage small-cell lung cancer with cyclophosphamide, doxorubicin, and vincristine with or without etoposide: a randomized trial of the North Central Cancer Treatment Group. J Clin Oncol 1990 Jan; 8(1):33-8.
     View PubMed
203. Grambsch PM, Kosanke JL, Therneau TM, Schaid DJ, Zinsmeister AR, Wieand HS, Offord KP, LarsonKeller JJ. The GLIM procedure: An interface to the SAS system. Proc 15th Annual SAS Users Group International Converence Cary SAS Institute, Inc 1990.
204. Therneau TM, Wieand HS, Chang MN. Optimal designs for a grouped sequential binomial trial. Biometrics 1990; 46:771-81.
205. Therneau TM, Grambsch P, Fleming T. Martingale based residuals for survival models Biometrika 1990; 77:147-60.
206. Schaid DJ, Wieand HS, Therneau TM. Optimal two-stage screening designs for survival comparisons. Biometrika 1990; 77(3):507-13.
207. Blute ML, Nativ O, Zincke H, Farrow GM, Therneau T, Lieber MM. Pattern of failure after radical retropubic prostatectomy for clinically and pathologically localized adenocarcinoma of the prostate: influence of tumor deoxyribonucleic acid ploidy. J Urol 1989 Nov; 142(5):1262-5.
     View PubMed
208. Tefferi A, Hoagland HC, Therneau TM, Pierre RV. Chronic myelomonocytic leukemia: natural history and prognostic determinants. Mayo Clin Proc 1989 Oct; 64(10):1246-54.
     View PubMed
209. Nativ O, Winkler HZ, Raz Y, Therneau TM, Farrow GM, Myers RP, Zincke H, Lieber MM. Stage C prostatic adenocarcinoma: flow cytometric nuclear DNA ploidy analysis. Mayo Clin Proc 1989 Aug; 64(8):911-9.
     View PubMed
210. Witzig TE, Gonchoroff NJ, Greipp PR, Katzmann JA, Stenson MJ, Habermann TM, Colgan JP, Therneau TM, Banks PM. Rapid S-phase determination of non-Hodgkin's lymphomas with the use of an immunofluorescence bromodeoxyuridine labeling index procedure. Am J Clin Pathol 1989 Mar; 91(3):298-301.
     View PubMed
211. Letendre L, Niedringhaus RD, Therneau TM, Gastineau DA, Goldberg RM, Gerstner JB, Mailliard JA, Gundlach WJ, Kardinal CG, Pierre RV. Treatment of acute nonlymphocytic leukemia in the elderly with intermediate high-dose cytosine arabinoside. Medical & Pediatric Oncology 1989; 17(2):79-82.
     View PubMed
212. Therneau TM, Solberg LA Jr, Jenkins RB. Modeling megakaryocyte development as a branching process. Comput Math Appl 1989; 18:959-964.
213. Loprinzi CL, Love RR, Therneau TM, Verman AK. Inhibition of human skin ornithine decarboxylase activity by oral alpha-diflouromethylornithine. Cancer Therapy and Control 1989; 1:75-80.
214. Blute ML, Tsushima K, Farrow GM, Therneau TM, Lieber MM. Transitional cell carcinoma of the renal pelvis: nuclear deoxyribonucleic acid ploidy studied by flow cytometry. J Urol 1988 Nov; 140(5):944-9.
     View PubMed
215. Witzig TE, Gonchoroff NJ, Katzmann JA, Therneau TM, Kyle RA, Greipp PR. Peripheral blood B cell labeling indices are a measure of disease activity in patients with monoclonal gammopathies. J Clin Oncol 1988 Jun; 6(6):1041-6.
     View PubMed
216. Winkler HZ, Rainwater LM, Myers RP, Farrow GM, Therneau TM, Zincke H, Lieber MM. Stage D1 prostatic adenocarcinoma: significance of nuclear DNA ploidy patterns studied by flow cytometry. Mayo Clin Proc 1988 Feb; 63(2):103-12.
     View PubMed
217. Eagan RT, Frytak S, Richardson RL, Creagan ET, Therneau TM, Coles DT, Jett JR. A randomized comparative trial of sequential versus alternating cyclophosphamide, doxorubicin, and cisplatin and mitomycin, lomustine, and methotrexate in metastatic non-small-cell lung cancer. J Clin Oncol 1988 Jan; 6(1):5-8.
     View PubMed
218. Myers RP, Therneau TM, Zincke H, Utz DC. Radical prostatectomy and the influence of early endocrine therpay for stage D1 prostate cancer: long-term follow-up study. A multidisciplining analysis of contraoversies in the management of prostate cancer pg 183-194 Plenum, New York, 1988.
219. Tibbits PA, Evaul JE, Goldstein RE, Boccuzzi SJ, Therneau TM, Parker R, Wong D. Serial acquisition of data to predict one-year mortality rate after acute myocardial infarction. Am J Cardiol 1 1987 Sept; 60:451-5.
220. Buck M, Ingle JN, Giuliani ER, Gordon JR, Therneau TM. Pericardial effusion in women with breast cancer. Cancer 1987 Jul 15; 60(2):263-9.
     View PubMed
221. Eagan RT, Frytak S, Lee RE, Therneau TM, Richardson RL, Creagan ET. No routine role for vincristine, adriamycin, and cyclophosphamide (VAC) or thoracic radiation therapy in extensive stage small cell lung cancer. Am J Clin Oncol 1987 Apr; 10(2):141-5.
     View PubMed
222. Eagan RT, Therneau TM, Rubin J, Long HJ, Schutt AJ. Lack of value for cisplatin added to mitomycin-doxorubicin combination chemotherapy for carcinoma of unknown primary site. A randomized trial. Am J Clin Oncol 1987 Feb; 10(1):82-5.
     View PubMed
223. Moss AJ, Bigger T, Carleen E, Fleiss JL, Odoroff CL, Rolnitecky LR, Therneau TM. The mortality risk associated with digitalis treatment after myocardial infarction. Cardiovasc Drugs and Therapy 1987; 1:125-32.
224. Wieand HS, Therneau TM. A two-stage design for randomized trials with binary outcome. Controlled Clin Trials 1987 1987; 8:20-8.
225. Chang MN, Therneau TM, Wieand HS, Cha SS. Designs for group sequential phase II clinical trials. Biometrics 1987; 43:865-74.
     View PubMed
226. Mailliard JA, Letendre L, Dalton RJ, Levitt R, Gerstner JB, Therneau TM, Pierre RV. Phase I-II trial of VP-16 in the treatment of acute nonlymphocytic leukemia and blast crisis of chronic granulocytic leukemia. Med Pediatr Oncol 1986; 14(6):306-9.
     View PubMed
227. Leerapun A, Suravarapu SV, Bida JP, Clark RJ, Sanders EL, Mettler TA, Stadheim LM, Aderca I, Moser CD, Nagorney DM, LaRusso NF, de Groen PC, Menon KV, Lazaridis KN, Gores GJ, Charlton MR, Roberts RO, Therneau TM, Katzmann JA, Roberts LR. The utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: evaluation in a United States referral population. Clin Gastroenterol Hepatol 2007 Mar; 5(3):394-402; quiz 267.
     View PubMed